Harvard Bioscience (HBIO) Change in Acquisitions & Divestments (2024)

Harvard Bioscience's (HBIO) quarterly Change in Acquisitions & Divestments came in at $1.4 million in Q3 2024, little changed on a QoQ basis from $1.4 million in Q2 2024.

Harvard Bioscience (HBIO) Change in Acquisitions & Divestments (2024) Analysis & Trends

Harvard Bioscience (HBIO) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $1.4 million in Q3 2024.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $1.4 million in Q3 2024; TTM through Jun 2025 was $1.4 million, a 26.12% decrease from a year earlier, with the FY2024 full-year figure at $1.9 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q3 2024 stood at $1.4 million, roughly flat from $1.4 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for HBIO reached as high as $1.4 million in Q2 2024 and fell as low as $495000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 126.19 Bn 120.97 Bn 1.96 Bn
2 Becton Dickinson 44.76 Bn 43.95 Bn 2.15 Bn
3 Alcon 32.93 Bn 31.28 Bn 1.53 Bn
4 Medline 32.80 Bn 30.56 Bn 1.84 Bn
5 Resmed 29.51 Bn 27.85 Bn 890.98 Mn
6 West Pharmaceutical Services 23.59 Bn 23.15 Bn 329.20 Mn
7 Solventum 14.01 Bn 13.45 Bn 1.10 Bn
8 Cooper Companies 13.77 Bn 13.63 Bn 735.40 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn
10 Harvard Bioscience 26.75 Mn 19.65 Mn 12.24 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 1.40 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 1.40 Mn
Jun 30, 2024 1.40 Mn
Mar 31, 2024 495,000.00
Mar 31, 2024 495,000.00